In the long aftermath of the pandemic, a large Chilean study has surfaced a sobering entanglement between two ancient adversaries of human health: severe COVID-19 and tuberculosis. Among 3.6 million adults tracked over two years, those hospitalized with the virus faced nearly nine times the risk of developing TB within the following year — a finding that suggests the body's most violent encounters with COVID-19 may leave immunological wounds that outlast the illness itself. The research, published in Nature Communications, adds a quieter chapter to the pandemic's toll, one written not in acute
News-Medical
· Jul 01, 2026
· health
· 4 min de leitura
High
Apuração: Verificado
Severe COVID-19 linked to eightfold TB risk spike, vaccination appears protective
Study identified 733 new TB cases among 3.6 million COVID-19 survivors, with elevated risk particularly affecting older, male, and migrant populations.
◉
Health & Medicine
8412 artigos relacionados
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% correspondência
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% correspondência
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% correspondência
Cobertura Relacionada
BBC News · Aug 25
School asbestos exposure linked to woman's death at 46, family claims
A woman died from mesothelioma at 46, likely exposed to asbestos at her Cardiff school decades earlier. Her family is su…
Future of Personal Health - · Aug 25 NGS Technology Transforms Uncertain Infections Into Actionable DiagnosesHybrid-capture NGS technology helps clinicians identify pathogens in diagnostically challenging cases by simultaneously …
The Guardian · Aug 25 Shark attack survivor Leah Stewart recalls 'monster' in first interview since losing armLeah Stewart, who lost her arm in a June shark attack at Coogee Beach, recalls the traumatic encounter in her first inte…
Education News Canada · Aug 25 Systemic racism, restrictive policies block Black Canadians from blood donationBlack Canadians face systemic barriers to blood donation despite critical need for ethnicity-matched blood for sickle ce…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Severe COVID-19 survivors face 8.9x higher TB risk within one year, with vaccination appearing protective, potentially reshaping post-pandemic disease surveillance strategies globally.
Escalation Risk
moderate
Confidence
HIGH
Chile
Low and middle-income countries with high TB burden
Sub-Saharan Africa
South Asia
Southeast Asia
Shifts focus toward vaccine equity and TB control as interconnected global health priorities; strengthens argument for sustained COVID-19 vaccination campaigns in TB-endemic regions; may increase dependency on high-income countries for vaccine access and TB diagnostics in vulnerable nations.
Similar to post-1918 influenza pandemic TB surge, where respiratory viral infections preceded tuberculosis waves; demonstrates cyclical pattern of pandemic-driven immunosuppression enabling dormant pathogen reactivation.
Lente Econômica
📈
Severe COVID-19 hospitalization increases TB risk 8.9-fold within one year, with vaccination appearing protective, creating potential healthcare costs and demand for TB screening services.
Market Signal
mixed
Confidence
HIGH
Healthcare and pharmaceuticals
Diagnostic testing and medical devices
Public health and disease surveillance
Vaccine development and distribution
Hospital and clinical services
COVID-19 survivors, particularly those hospitalized, face elevated TB infection risk requiring post-hospitalization screening and potential treatment, increasing out-of-pocket healthcare costs and insurance claims. Vaccination uptake may increase as protective benefit is demonstrated.
Governments likely to implement mandatory TB screening protocols for severe COVID-19 survivors, increase TB surveillance funding, and strengthen vaccination campaigns. Public health agencies may establish post-COVID care guidelines. Healthcare systems may face increased diagnostic and treatment expenditures.